Ironwood Pharmaceuticals Appoints Alexander Denner, Ph.D., to Board of Directors
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-Appoints-Alexander-Denner-Ph.D.-to-Board-of-Directors/default.aspx
Ironwood Pharmaceuticals Reports Strong Third Quarter 2020 Results and Increases Full Year 2020 Financial Guidance
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-Reports-Strong-Third-Quarter-2020-Results-and-Increases-Full-Year-2020-Financial-Guidance/default.aspx
Ironwood Pharmaceuticals Appoints Alexander Denner, Ph.D., to Board of Directors
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-Appoints-Alexander-Denner-Ph.D.-to-Board-of-Directors/default.aspx
Ironwood Pharmaceuticals to Host Third Quarter 2020 Investor Update Call
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-to-Host-Third-Quarter-2020-Investor-Update-Call/default.aspx
Ironwood Pharmaceuticals to Host Third Quarter 2020 Investor Update Call
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-to-Host-Third-Quarter-2020-Investor-Update-Call/default.aspx
Ironwood to Discontinue IW-3718 Development Program Following Results from Planned Efficacy Assessment
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-to-Discontinue-IW-3718-Development-Program-Following-Results-from-Planned-Efficacy-Assessment/default.aspx
Ironwood to Discontinue IW-3718 Development Program Following Results from Planned Efficacy Assessment
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-to-Discontinue-IW-3718-Development-Program-Following-Results-from-Planned-Efficacy-Assessment/default.aspx
Ironwood Pharmaceuticals to Participate in Upcoming September Investor Conferences
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-to-Participate-in-Upcoming-September-Investor-Conferences/default.aspx
Ironwood Pharmaceuticals to Participate in Upcoming September Investor Conferences
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-to-Participate-in-Upcoming-September-Investor-Conferences/default.aspx
Ironwood Pharmaceuticals Reports Second Quarter 2020 Results; Delivered GAAP Net Income of $25 Million and Adjusted EBITDA of $33 Million
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-Reports-Second-Quarter-2020-Results-Delivered-GAAP-Net-Income-of-25-Million-and-Adjusted-EBITDA-of-33-Million/default.aspx